Codexis, Inc. (CDXS)
NASDAQ: CDXS · IEX Real-Time Price · USD
3.340
+0.230 (7.40%)
At close: May 2, 2024, 4:00 PM
3.550
+0.210 (6.29%)
Pre-market: May 3, 2024, 8:45 AM EDT

Codexis Revenue

Codexis had revenue of $74.23M in the twelve months ending March 31, 2024, down -36.13% year-over-year. Revenue in the quarter ending March 31, 2024 was $17.07M with 31.51% year-over-year growth. In the year 2023, Codexis had annual revenue of $70.14M, a decrease of -49.39%.

Revenue (ttm)
$74.23M
Revenue Growth
-36.13%
P/S Ratio
3.17
Revenue / Employee
$426,632
Employees
174
Market Cap
235.66M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202370.14M-68.45M-49.39%
Dec 31, 2022138.59M33.84M32.30%
Dec 31, 2021104.75M35.70M51.69%
Dec 31, 202069.06M598.00K0.87%
Dec 31, 201968.46M7.86M12.98%
Dec 31, 201860.59M10.57M21.13%
Dec 31, 201750.02M1.19M2.43%
Dec 31, 201648.84M7.03M16.82%
Dec 31, 201541.80M6.50M18.40%
Dec 31, 201435.31M3.39M10.60%
Dec 31, 201331.92M-56.38M-63.85%
Dec 31, 201288.30M-35.57M-28.71%
Dec 31, 2011123.87M16.76M15.65%
Dec 31, 2010107.10M24.20M29.18%
Dec 31, 200982.91M32.43M64.25%
Dec 31, 200850.48M25.15M99.26%
Dec 31, 200725.33M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
AngioDynamics 324.01M
Puma Biotechnology 226.63M
G1 Therapeutics 84.04M
AVITA Medical 51.57M
Utah Medical Products 50.22M
Metagenomi 44.76M
AC Immune 17.62M
Veru Inc. 15.93M
Revenue Rankings